Abstract
Long-term memories are created when labile short-term memory traces are converted to more enduring forms. This process, called consolidation, is associated with changes in the synthesis of proteins that alter the biophysical properties of neurons and the strength of their synaptic connections. Recently, it has become clear that the consolidation process requires not only protein synthesis but also degradation. Here, we discuss recent findings on the roles of ubiquitination and protein degradation in synaptic plasticity and learning and memory.
Keywords: ubiquitin, neuron, learning, memory, plasticity, proteasome
Introduction
The formation of long-term memories is thought to occur in stages, involving acquisition and consolidation. During acquisition, the animal learns new information, the memory for which is short-lasting (short-term memory). Through the process of consolidation, this short-term memory is converted to a more permanent form, which is available for subsequent retrieval. Historically, long-term memory (LTM) formation was synonymous with increased gene expression and protein synthesis [21, 45]. Undoubtedly, gene transcription and translation are necessary for LTM, but recent results indicate that protein degradation may be equally important [3, 56]. According to the emerging view, degradation of subsets of proteins may remove inhibitory constraints on memory formation [13]. Together with protein synthesis, protein degradation regulates the availability of synaptic proteins thereby modulating synaptic strength and plasticity, and ultimately memory formation [11].
Regulated degradation of proteins occurs via three main routes: the lysosome, proteases including calpain, thrombin, neurotrypsin and matrix metalloproteinases, and the ubiquitin-proteasome system (UPS)[30, 86, 90, 93, 94]. All three routes have been involved in the regulation of cellular signaling and synaptic plasticity, and by extension, in learning and memory [16, 36, 55, 81, 86, 90, 93, 94]. Here, we will focus on the UPS, the major protein degradation pathway involved in the destruction of cytoplasmic targets.
Protein degradation via the ubiquitin-proteasome system
Degradation of proteins via the UPS involves three basic steps: the identification of the target protein, the tagging of the target protein with a ubiquitin chain, and the delivery of the tagged target protein to the 26S proteasome, which degrades ubiquitinated proteins [30] (Fig. 1). Ubiquitination, the covalent addition of ubiquitin molecules on target proteins, plays a role in numerous cellular processes including cell cycle regulation, signal transduction, gene transcription and synaptic plasticity [36, 40, 71, 81, 91]. The ubiquitination of target proteins is highly regulated, involving three families of enzymes. First, ubiquitin is activated by a ubiquitin-activating enzyme called E1. Then, activated ubiquitin is transferred to a ubiquitin-conjugating enzyme called E2, which associates with another enzyme, a ubiquitin ligase called E3. The E3 attaches the ubiquitin to a lysine residue in the target protein. Formation of a polyubiquitin chain is initiated with the covalent addition of a second ubiquitin moiety to the first ubiquitin. A large degree of diversity exists among E3s, and some among E2s. The specificity in the ubiquitination process is due to the combinatorial mechanism involving E2s and E3s as well as the physiological state of the target protein (e.g., phosphorylation) [36, 100].
Figure 1.
The ubiquitin-proteasome system (UPS). Ubiquitin molecules are attached to a target protein via the coordinated action of E1, E2 and E3. Most polyubiquitinated substrates are degraded by the 26S proteasome. Monomeric ubiquitin is recycled by deubiquitinating enzymes (DUBs) such as ubiquitin carboxy-terminal hydrolase. Modified from [37].
Once tagged, the target protein is destined for degradation by the 26S proteasome, a large protein complex located in the nucleus and cytosol of cells. The proteasome is formed by the co-assembly of a core catalytic component with a sedimentation coefficient of 20S and a 19S cap (the regulatory component). The 19S cap is involved in the initial recognition of the polyubiquitin chain on the target protein. Although the target protein is degraded, the polyubiquitin chain is generally not. Deubiquitinating enzymes (DUBs) including ubiquitin C-terminal hydrolases (UCH) and ubiquitin-specific proteases cleave the ubiquitin moieties, which are recycled. Under certain conditions, however, they, too, can be degraded [50, 72, 77].
The UPS and synaptic plasticity
The UPS is well poised to regulate synaptic transmission and plasticity. Components of the UPS are localized near both pre- and postsynaptic regions of synapses [8, 25, 68, 83]. The postsynaptic localization in particular is thought to be dynamically regulated by synaptic activity, because stimulation with KCl or NMDA induces calcium-calmodulin kinase II (CaMKII)-dependent redistribution of the proteasome from dendritic shafts to spines [8, 9]. Furthermore, the levels of several synaptic proteins are regulated by the UPS, including presynaptic regulators of the synaptic vesicle cycle [2, 14, 26, 42, 83], scaffold proteins [19, 25] and postsynaptic receptors [10, 25, 60, 68] (for a review see [57]). Because of its subcellular localization and its targets, the role of the UPS in synaptic plasticity has been studied extensively in recent years (for reviews see [11, 36, 86]). We will briefly discuss pharmacological and genetic studies that have implicated the UPS in long-term forms of synaptic plasticity thought to contribute to learning and memory [58, 61, 84].
The significance of the UPS as a regulator of long-term plasticity is evidenced by its conserved role across phyla. In the invertebrate Aplysia, the UPS is necessary for long-term facilitation (LTF) [39, 88, 101]. In mammals, proteasomal activity is required for long-term potentiation (LTP), although there is disagreement about the role of the proteasome in the two phases of LTP (i.e., early and late LTP). Early LTP (E-LTP) lasts 1-2 h post-induction and involves calcium influx (through NMDA receptors), CamKII and increased surface expression of AMPA receptors [58]. In the hippocampus, pharmacological inhibition of the proteasome has been reported to enhance [24], inhibit [46] or not affect [28] this early phase. These discrepancies have been attributed to the specificity and concentrations of the inhibitors that have been used [24]. Late LTP (L-LTP) is a temporally and mechanistically distinct phase of LTP that lasts several hours post induction and requires protein synthesis and gene transcription [58]. Blocking proteasomal activity impairs the maintenance of L-LTP [24, 28, 46]. Intriguingly, the same manipulation alleviates the requirement of protein synthesis for L-LTP [28], suggesting that the expression of L-LTP depends on a balance between protein synthesis and degradation.
In addition to synaptic potentiation, the UPS is important for long-term synaptic depression (LTD) in invertebrates [26] and mammals [17, 19, 22, 41]. In the entorhinal cortex and the hippocampus, pharmacological inhibition of the proteasome blocks NMDA receptor-dependent LTD [19, 22] and metabotropic glutamate receptor (mGluR)-dependent LTD [41]. However, two recent studies challenged these results, reporting that in the hippocampus and nucleus accumbens, inhibition of proteasomal function had no effect on NMDA receptor-mediated LTD whereas the same manipulation enhanced mGluR-dependent LTD [17, 60]. The reason for these discrepancies is not clear, yet it is intriguing that the UPS may regulate the same form of synaptic plasticity differentially, depending on the induction mechanism.
The involvement of the UPS in synaptic plasticity and the finding that deficits in synaptic plasticity and its underlying mechanisms are implicated in memory impairments [7, 67, 79] have motivated investigations into the role of the UPS in learning and memory. Here we review recent work supporting this role.
The UPS and memory consolidation
The relationship between the UPS and the various stages of memory has been investigated through pharmacological and genetic studies. Using specific inhibitors of the UPS [62], Lopez-Salon et al. [56] tested the requirement for the UPS in hippocampal-dependent learning and memory. At various times after inhibitory avoidance training, during which rats learned to stay on a platform in order to avoid an electric shock, the proteasome inhibitor lactacystin or proteasome inhibitor I was infused into the dorsal CA1 region of hippocampus. When the inhibitors were administered 1-7 h after training, performance on the task 24 h after training was diminished. In contrast, the inhibitors were ineffective when infused 10 h after training. These results indicate that memory for inhibitory avoidance requires the function of UPS up to 7 h after training and suggested that UPS-mediated proteolysis is important for the consolidation phase of the memory [but see 53], but not its retrieval. Similar conclusions were reached by Artinian et al. [3] using the spatial Morris water maze task (which requires the animal to learn the location of a hidden platform over several training sessions using distal cues, in order to escape the water), although the time window during which UPS function was needed for consolidation varied (immediately but not 3 h after training). Lopez-Salon et al. [56] also found that protein ubiquitination and 26S proteolytic activity were increased in the hippocampus for at least 4 h after training [56], further supporting the requirement for UPS function in the early events of memory consolidation.
Genetic studies have manipulated various components of the UPS in order to determine its role in the formation of LTM. These components include certain ubiquitin ligases [5, 43, 95, 97], ubiquitin ligase-related adaptor proteins [54] and deubiquitinating enzymes [31, 76, 92] [for review on mouse models of UPS dysfunction see 89]. The E3 ligases (Fig. 1) have been a particular focus of studies using loss-of-function mutations. One such ligase is the UBE3a ubiquitin ligase (a.k.a. E6-AP). Mutations in the Ube3a locus give rise to Angelman syndrome (AS), an inherited neurological disorder involving motor dysfunction and intellectual disability [49]. It seems likely that the deficits in AS are due at least in part to alterations in synaptic plasticity associated with the absence of UBE3a. Specifically, the neocortex of mice that possess a maternal Ube3a null mutation shows delayed experience-dependent maturation [97]. Moreover, neocortical LTP and LTD are impaired, as is ocular dominance plasticity [97]. Whereas basal synaptic transmission is normal in the hippocampus of these mutants, hippocampal synaptic plasticity is not. LTP is significantly attenuated for up to 80 min after its induction (E-LTP) [43].
The role of UBE3a and the UPS in long-term memory formation was investigated in the maternal Ube3a mutant mice using various behavioral learning tasks [43]. In context fear conditioning, the animal learns to associate their immediate environment (context) with an aversive stimulus (e.g., electric shock) (also see Fig. 3). This type of learning is generally believed to be hippocampus-dependent [48]. In cued fear conditioning, an association is made between a salient cue (e.g., a tone) and the aversive stimulus, and this type of learning is thought to depend primarily on the amygdala [70]. Ube3a mutant mice performed poorly compared to controls in the context-dependent conditioning task but performed at control levels in the cue-dependent conditioning task, suggesting that UBE3a function is necessary for memories involving the hippocampus [43]. The lack of an effect on cued-fear conditioning does not agree with the observation that various components of the UPS are upregulated in the amygdala in response to this type of learning [85]. However, as we will discuss below, several studies have found no requirement for the UPS in cued-fear conditioning, questioning the functional relevance of the increases in expression observed by Stork et al. [85]. Indeed, fear-potentiated startle, which involves the amygdala, is facilitated following proteasome inhibition [98].
Figure 3.
Schematic of a typical experiment to test memory reconsolidation. During fear conditioning training, a conditioned stimulus (CS; e.g., context) is paired with an unconditioned stimulus (US; e.g., electric shock). Twenty four h after training, the CS is presented alone (retrieval 1) and the freezing response of the animal (fear memory) is measured. Subsequently, a drug (e.g., proteasome inhibitor) or vehicle is infused and the animal is retested 24 h later for fear memory (retrieval 2). If the drug interferes with reconsolidation, freezing during retrieval 2 should be impaired compared to vehicle. Modified from [44].
Work in Drosophila corroborates the link between mutations in Ube3a and deficient memory formation found in the mammalian studies. Loss-of-function mutations in the dube3a gene, which codes for the fly homologue of UBE3a, result in failure to form long-term memory for an olfactory conditioning task [95]. This memory deficit is not due to a failure to learn the association between the odor and the shock used in the task, because immediately after training, mutant animals perform at wild-type control levels [95]. Notably, the mutation does not impair all types of memory in the fly. Mutant animals perform similar to wild types when tested in a different version of the olfactory conditioning task that induces a type of memory not requiring protein synthesis [95].
Progress is being made in identifying proteins whose degradation is regulated by UBE3a. Greer et al. [33] recently identified Arc, a synaptic protein that promotes internalization of AMPA glutamate receptors [15, 73, 78], as a target for UBE3a. UBE3a ubiquitinates Arc, leading to its degradation through the UPS. In the absence of UBE3a, Arc levels increase in the hippocampus. This loss of control over Arc levels and the consequent reduction in synaptic AMPA receptors impair hippocampal synaptic function [33]. The decrease in AMPA receptors could explain the previously observed deficit in LTP and the failure to form context-dependent fear memories [43], but these hypotheses remain to be tested.
Additional components of the UPS implicated in memory formation include the ubiquitin ligase UBR1 [5] and the adaptor protein CDH1 [54]. UBR1 is part of the N-end rule pathway, which functions to destabilize the N-terminus of target proteins prior to their degradation by the 26S proteasome [51]. When tested in the hidden platform version of the Morris water maze task, mice lacking UBR1 show impaired long-term memory, with no apparent differences in the initial learning of the task [5]. CDH1 is an adaptor protein that brings substrates to the anaphase promoting complex, an important multi-subunit E3 ubiquitin ligase with several pre- and post-mitotic functions [59, 80, 96]. Brain slices from Cdh1 heterozygous knockout mice show normal synaptic transmission and E-LTP in the CA1 area of the hippocampus, but show impaired L-LTP [54]. Moreover, cdh1 heterozygotes perform poorly in contextual-fear conditioning but at control levels in cued-fear conditioning [54]. This finding agrees well with the observations of Jiang et al. [43] and corroborates the involvement of regulated proteolysis in hippocampus-dependent memory formation.
Tagging of target proteins by ubiquitin ligases is an important aspect of the UPS system, but so is cleavage of the polyubiquitin chain prior to target degradation and recycling of ubiquitin [50]. Several lines of research point to the involvement of DUBs in development, transcription regulation and neurological disorders [47]. With regard to learning and memory, the UCH family of DUBs has attracted particular attention [36, 37]. Pioneering studies in Aplysia have provided significant insight into the role of the UPS and UCH in memory-related synaptic plasticity. LTF, a form of plasticity thought to underlie long-term memory for sensitization in this animal [18, 29], is associated with persistent activation of protein kinase A (PKA) in the absence of persistently increased cAMP levels [32, 64]. This persistent activation results from the degradation of the PKA regulatory subunits via the UPS [38]. LTF requires PKA activity and the proteasome [12]. Treatments that induce LTF also increase expression of the Aplysia homologue of UCHL1, Ap-UCH [39]. Ap-UCH, which is necessary for LTF, is associated with the proteasome and regulates the rate of degradation by the proteasome [39]. In a simple computational model (Fig. 2), PKA, which is initially activated by elevated cAMP, leads to induction of Ap-UCH, which in turn enhances PKA activity through degradation of its regulatory subunits, thus prolonging the availability of free, active catalytic subunits [69, 82]. Persistent PKA activity is likely to help maintain phosphorylation and activation of transcription factors, thereby contributing to the consolidation and persistence of later phases of LTF and long-term memory.
Figure 2.
PKA positive feedback loop. Serotonin (5-HT) triggers production of cAMP, which activates PKA and causes dissociation of the regulatory (R) and catalytic (C) subunits. The catalytic subunit translocates to the nucleus, where it activates transcription factors (TF1, TF2) that regulate expression of genes including Ap-UCH. Increased Ap-UCH contributes to the degradation of the regulatory subunit of PKA, thus forming a positive feedback loop that sustains elevated PKA activity.
Ap-UCH is involved not only in LTF but also in LTD. In Aplysia, LTD requires the proteasome and correlates with increased ubiquitination levels. Treatments that induce LTD also upregulate Ap-UCH expression via the transcription factor CREB2 [26]. If Ap-UCH is involved in both LTF and LTD, how is the direction of the plasticity determined? One possible explanation is that the directionality in plasticity comes from the identity of the target proteins, which is determined by the combination of E2s and E3s [99], and probably not by DUBs.
The function of UCHs in plasticity and memory is evolutionarily conserved. In rodents, UCH is upregulated in the hippocampus following passive avoidance training [27]. UCHL1, the mammalian homologue of Ap-UCH, is required for L-LTP in the CA1 region of the hippocampus [76]. Moreover, a specific UCHL1 inhibitor impairs contextual fear conditioning, but not cued-fear conditioning [31]. By varying the time of administration of the inhibitor in relation to training, Gong et al. [31] found that the hydrolytic activity of UCHL1 was required for consolidation of contextual fear memory, but not for its acquisition. However, hippocampal LTP and contextual fear conditioning are intact in mice lacking UCHL3, a related member of the UCH family of DUBs [92], suggesting that different DUBs have selective functions in distinct paradigms of plasticity and memory.
The requirement for UCHL1 in hippocampal-dependent memory formation was corroborated by a later study using UCHL1-deficient gracile axonal dystrophy (gad) mice [76]. These mice carry a spontaneous mutation that produces in a deletion in exons 7 and 8 of Uchl1, resulting in no detectable expression of UCHL1 [75]. To test for memory impairments, gad mice and wild type controls were trained in a passive avoidance task, in which animals learn to prefer a brightly lit compartment over a dark one, after the association of the latter with an electrical shock. When tested 2 h after training, gad mice performed similar to controls, suggesting that their learning ability was intact. However, when tested 24 h after training, gad mice performed poorly, suggesting that the absence of UCHL1 reduced the persistence of passive avoidance memory [76].
The UPS and memory reconsolidation
The dynamic nature of memory formation lies at the core of the concept of memory reconsolidation. When a previously acquired memory is retrieved, it becomes labile and susceptible to remodeling [35, 65]. The re-establishment of the memory is termed reconsolidation. Although the mechanisms underlying the destabilization and restabilization of the memory after its retrieval are becoming better understood [87], the functional significance of the reconsolidation process remains elusive. Lee [52] recently proposed that reconsolidation, rather than consolidation, is the predominant process taking place whenever more than a single training trial is involved.
The requirement for new protein synthesis in reconsolidation ([1, 87] but see [63]) could be explained if reactivated memories were destroyed via the UPS. If so, then inhibiting the UPS during reconsolidation should alleviate the need for new protein synthesis. Lee et al. [53] performed precisely this experiment [see also Fig. 3 and ref. 44]. Mice were trained in a context-fear conditioning paradigm, and 24 h after training the memory was reactivated with a retrieval trial (Retrieval 1). Subsequently, the proteasome inhibitor β-lactone was infused along with the protein synthesis inhibitor anisomycin bilaterally in the hippocampus and memory retrieval was re-tested (Retrieval 2) 24 h later. As expected [e.g., 66], treatment with anisomycin alone impaired performance during Retrieval 2, which suggested deficient reconsolidation. However, co-administration of the UPS inhibitor blocked the amnesic effect of anisomycin, supporting the idea that the UPS destabilizes the reactivated memory and that new protein synthesis is required to restabilize it. The same conclusion was reached by Lee [52], who also found that co-administration of β-lactone mitigated the amnesic effect of anisomycin on reconsolidation of contextual fear conditioning.
Additional evidence for the role of the UPS in reconsolidation was provided through experiments in which the timing of the infusion of the UPS inhibitor (in this case, lactacystin) varied [3]. Hippocampal injection of lactacystin immediately after reactivation of spatial memory for a hidden platform in the Morris water maze impaired retrieval 24 h later, suggesting that reconsolidation of the spatial memory was blocked. However, when lactacystin injection was delayed for 3 h post reactivation, no effect on reconsolidation was observed [3]. These results agree with the observation of Lee et al. [53] that polyubiquitination levels are increased for at least 60 min following memory reactivation, and point to a narrow window following memory reactivation during which UPS function is indispensible. Note, however, that whereas blocking the proteasome impaired reconsolidation in the Artinian et al. [3] study, the same manipulation did not affect reconsolidation in the Lee et al. [53] study. Notably, Lee et al. did not find an effect of proteasome inhibition even on consolidation. The reasons for these discrepancies remain unclear but could involve procedure-specific differences [53, 74].
Future directions
An appreciation for the role of protein degradation by the UPS in learning and memory is rapidly gaining momentum. Proposed functions of the UPS include removal of inhibitory constraints on memory formation [4, 6, 13, 24, 28], destabilization of synapses to allow for new learning [56], and destabilization of previously learned memories (“unlearning”), implicated in behavioral extinction [53]. However, many fundamental questions remain to be answered. For example, which proteins are targeted by the UPS during learning and memory and what is the functional significance of their degradation? One such protein is the postsynaptic scaffold molecule Shank, which, consistent with previous in vitro work [25], is degraded by the UPS after memory retrieval [53]. The down-regulation of scaffold molecules could destabilize the postsynaptic density and modulate synaptic strength through receptor internalization [19], thus affecting the state of the memory. NCAM, the neural cell adhesion molecule, is also ubiquitinated and down-regulated following passive avoidance training [27], consistent with the hypothesis of synapse destabilization and reorganization during memory consolidation [56].
In addition to identifying the targets of the UPS during learning and memory, future work needs to determine the mechanisms through which proteasomal activity is regulated during consolidation and/or reconsolidation of different types of memory. Some insight into UPS regulation can be gained from recent in vitro work suggesting that synaptic activity upregulates proteasomal function in a manner dependent on calcium influx (through NMDA receptors and L-type voltage gated calcium channels) and CamKII [23]. This activity-dependent regulation of the proteasome appears to be bidirectional because proteasomal function is down-regulated when action potentials are blocked with tetrototoxin [23]. A related question is whether proteasomal activity is differentially regulated for a memory produced by a single training trial vs. a memory that is acquired through repeated training trials (sessions) [52] and if so, how this regulation is achieved. Differential involvement of the UPS in memories acquired through a single training trial (e.g., during contextual fear training) vs. those acquired through repeated trials (e.g., Morris water maze) could perhaps explain discrepancies between studies (e.g., between [3, 53]) (see memory reconsolidation section and [74]). The generation of new research tools such as fluorescent reporters targeted by the UPS [20, 34] will allow the in vivo monitoring of proteasome function and direct assessment of its role during various learning paradigms.
Acknowledgments
We thank Lorenzo Morales for help with the illustrations and Evangelos Antzoulatos, Len Cleary, Paul Smolen and Yili Zhang for comments on a previous version of the manuscript. Supported by NIH grants NS019895 and MH058321.
Footnotes
Conflict of Interest Statement The authors declare that there are no conflicts of interest.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Alberini CM. Mechanisms of memory stabilization: are consolidation and reconsolidation similar or distinct processes? Trends Neurosci. 2005;28:51–56. doi: 10.1016/j.tins.2004.11.001. [DOI] [PubMed] [Google Scholar]
- 2.Aravamudan B, Broadie K. Synaptic Drosophila UNC-13 is regulated by antagonistic G-protein pathways via a proteasome-dependent degradation mechanism. J Neurobiol. 2003;54:417–438. doi: 10.1002/neu.10142. [DOI] [PubMed] [Google Scholar]
- 3.Artinian J, McGauran AM, De Jaeger X, Mouledous L, Frances B, Roullet P. Protein degradation, as with protein synthesis, is required during not only long-term spatial memory consolidation but also reconsolidation. Eur J Neurosci. 2008;27:3009–3019. doi: 10.1111/j.1460-9568.2008.06262.x. [DOI] [PubMed] [Google Scholar]
- 4.Ashraf SI, McLoon AL, Sclarsic SM, Kunes S. Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell. 2006;124:191–205. doi: 10.1016/j.cell.2005.12.017. [DOI] [PubMed] [Google Scholar]
- 5.Balogh SA, McDowell CS, Denenberg VH. Behavioral characterization of mice lacking the ubiquitin ligase UBR1 of the N-end rule pathway. Genes Brain Behav. 2002;1:223–229. doi: 10.1034/j.1601-183x.2002.10404.x. [DOI] [PubMed] [Google Scholar]
- 6.Banerjee S, Neveu P, Kosik KS. A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron. 2009;64:871–884. doi: 10.1016/j.neuron.2009.11.023. [DOI] [PubMed] [Google Scholar]
- 7.Bergado JA, Almaguer W. Aging and synaptic plasticity: a review. Neural Plast. 2002;9:217–232. doi: 10.1155/NP.2002.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bingol B, Schuman EM. Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature. 2006;441:1144–1148. doi: 10.1038/nature04769. [DOI] [PubMed] [Google Scholar]
- 9.Bingol B, Wang CF, Arnott D, Cheng D, Peng J, Sheng M. Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. Cell. 2010;140:567–578. doi: 10.1016/j.cell.2010.01.024. [DOI] [PubMed] [Google Scholar]
- 10.Burbea M, Dreier L, Dittman JS, Grunwald ME, Kaplan JM. Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate receptors at postsynaptic elements in C. elegans. Neuron. 2002;35:107–120. doi: 10.1016/s0896-6273(02)00749-3. [DOI] [PubMed] [Google Scholar]
- 11.Cajigas IJ, Will T, Schuman EM. Protein homeostasis and synaptic plasticity. Embo J. 2010;29:2746–2752. doi: 10.1038/emboj.2010.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chain DG, Casadio A, Schacher S, Hegde AN, Valbrun M, Yamamoto N, Goldberg AL, Bartsch D, Kandel ER, Schwartz JH. Mechanisms for generating the autonomous cAMP-dependent protein kinase required for long-term facilitation in Aplysia. Neuron. 1999;22:147–156. doi: 10.1016/s0896-6273(00)80686-8. [DOI] [PubMed] [Google Scholar]
- 13.Chain DG, Schwartz JH, Hegde AN. Ubiquitin-mediated proteolysis in learning and memory. Mol Neurobiol. 1999;20:125–142. doi: 10.1007/BF02742438. [DOI] [PubMed] [Google Scholar]
- 14.Chin LS, Vavalle JP, Li L. Staring, a novel E3 ubiquitin-protein ligase that targets syntaxin 1 for degradation. J Biol Chem. 2002;277:35071–35079. doi: 10.1074/jbc.M203300200. [DOI] [PubMed] [Google Scholar]
- 15.Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N, Kuhl D, Huganir RL, Worley PF. Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron. 2006;52:445–459. doi: 10.1016/j.neuron.2006.08.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting, Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. 2006:1–12. 505–506. doi: 10.1182/asheducation-2006.1.1. [DOI] [PubMed] [Google Scholar]
- 17.Citri A, Soler-Llavina G, Bhattacharyya S, Malenka RC. N-methyl-D-aspartate receptor- and metabotropic glutamate receptor-dependent long-term depression are differentially regulated by the ubiquitin-proteasome system. Eur J Neurosci. 2009;30:1443–1450. doi: 10.1111/j.1460-9568.2009.06950.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cleary LJ, Lee WL, Byrne JH. Cellular correlates of long-term sensitization in Aplysia. J Neurosci. 1998;18:5988–5998. doi: 10.1523/JNEUROSCI.18-15-05988.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Colledge M, Snyder EM, Crozier RA, Soderling JA, Jin Y, Langeberg LK, Lu H, Bear MF, Scott JD. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron. 2003;40:595–607. doi: 10.1016/s0896-6273(03)00687-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol. 2000;18:538–543. doi: 10.1038/75406. [DOI] [PubMed] [Google Scholar]
- 21.Davis HP, Squire LR. Protein synthesis and memory: a review. Psychol Bull. 1984;96:518–559. [PubMed] [Google Scholar]
- 22.Deng PY, Lei S. Long-term depression in identified stellate neurons of juvenile rat entorhinal cortex. J Neurophysiol. 2007;97:727–737. doi: 10.1152/jn.01089.2006. [DOI] [PubMed] [Google Scholar]
- 23.Djakovic SN, Schwarz LA, Barylko B, DeMartino GN, Patrick GN. Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II. J Biol Chem. 2009;284:26655–26665. doi: 10.1074/jbc.M109.021956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Dong C, Upadhya SC, Ding L, Smith TK, Hegde AN. Proteasome inhibition enhances the induction and impairs the maintenance of late-phase long-term potentiation. Learn Mem. 2008;15:335–347. doi: 10.1101/lm.984508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ehlers MD. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci. 2003;6:231–242. doi: 10.1038/nn1013. [DOI] [PubMed] [Google Scholar]
- 26.Fioravante D, Liu RY, Byrne JH. The ubiquitin-proteasome system is necessary for long-term synaptic depression in Aplysia. J Neurosci. 2008;28:10245–10256. doi: 10.1523/JNEUROSCI.2139-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Foley AG, Hartz BP, Gallagher HC, Ronn LC, Berezin V, Bock E, Regan CM. A synthetic peptide ligand of neural cell adhesion molecule (NCAM) IgI domain prevents NCAM internalization and disrupts passive avoidance learning. J Neurochem. 2000;74:2607–2613. doi: 10.1046/j.1471-4159.2000.0742607.x. [DOI] [PubMed] [Google Scholar]
- 28.Fonseca R, Vabulas RM, Hartl FU, Bonhoeffer T, Nagerl UV. A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP. Neuron. 2006;52:239–245. doi: 10.1016/j.neuron.2006.08.015. [DOI] [PubMed] [Google Scholar]
- 29.Frost WN, Castellucci VF, Hawkins RD, Kandel ER. Monosynaptic connections made by the sensory neurons of the gill- and siphon-withdrawal reflex in Aplysia participate in the storage of long-term memory for sensitization. Proc Natl Acad Sci U S A. 1985;82:8266–8269. doi: 10.1073/pnas.82.23.8266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002;82:373–428. doi: 10.1152/physrev.00027.2001. [DOI] [PubMed] [Google Scholar]
- 31.Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, Moolman D, Zhang H, Shelanski M, Arancio O. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell. 2006;126:775–788. doi: 10.1016/j.cell.2006.06.046. [DOI] [PubMed] [Google Scholar]
- 32.Greenberg SM, Castellucci VF, Bayley H, Schwartz JH. A molecular mechanism for long-term sensitization in Aplysia. Nature. 1987;329:62–65. doi: 10.1038/329062a0. [DOI] [PubMed] [Google Scholar]
- 33.Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, Flavell SW, Kim TK, Griffith EC, Waldon Z, Maehr R, Ploegh HL, Chowdhury S, Worley PF, Steen J, Greenberg ME. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell. 2010;140:704–716. doi: 10.1016/j.cell.2010.01.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hamer G, Matilainen O, Holmberg CI. A photoconvertible reporter of the ubiquitin-proteasome system in vivo. Nat Methods. 2010;7:473–478. doi: 10.1038/nmeth.1460. [DOI] [PubMed] [Google Scholar]
- 35.Hartley CA, Phelps EA. Changing fear: the neurocircuitry of emotion regulation. Neuropsychopharmacology. 2010;35:136–146. doi: 10.1038/npp.2009.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hegde AN. The ubiquitin-proteasome pathway and synaptic plasticity. Learn Mem. 2010;17:314–327. doi: 10.1101/lm.1504010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hegde AN, DiAntonio A. Ubiquitin and the synapse. Nat Rev Neurosci. 2002;3:854–861. doi: 10.1038/nrn961. [DOI] [PubMed] [Google Scholar]
- 38.Hegde AN, Goldberg AL, Schwartz JH. Regulatory subunits of cAMP-dependent protein kinases are degraded after conjugation to ubiquitin: a molecular mechanism underlying long-term synaptic plasticity. Proc Natl Acad Sci U S A. 1993;90:7436–7440. doi: 10.1073/pnas.90.16.7436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hegde AN, Inokuchi K, Pei W, Casadio A, Ghirardi M, Chain DG, Martin KC, Kandel ER, Schwartz JH. Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell. 1997;89:115–126. doi: 10.1016/s0092-8674(00)80188-9. [DOI] [PubMed] [Google Scholar]
- 40.Hochstrasser M. Ubiquitin signalling: what’s in a chain? Nat Cell Biol. 2004;6:571–572. doi: 10.1038/ncb0704-571. [DOI] [PubMed] [Google Scholar]
- 41.Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron. 2006;51:441–454. doi: 10.1016/j.neuron.2006.07.005. [DOI] [PubMed] [Google Scholar]
- 42.Jiang X, Litkowski PE, Taylor AA, Lin Y, Snider BJ, Moulder KL. A role for the ubiquitin-proteasome system in activity-dependent presynaptic silencing. J Neurosci. 2010;30:1798–1809. doi: 10.1523/JNEUROSCI.4965-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 1998;21:799–811. doi: 10.1016/s0896-6273(00)80596-6. [DOI] [PubMed] [Google Scholar]
- 44.Kaang BK, Lee SH, Kim H. Synaptic protein degradation as a mechanism in memory reorganization. Neuroscientist. 2009;15:430–435. doi: 10.1177/1073858408331374. [DOI] [PubMed] [Google Scholar]
- 45.Kandel ER. The molecular biology of memory storage: a dialog between genes and synapses. Biosci Rep. 2001;21:565–611. doi: 10.1023/a:1014775008533. [DOI] [PubMed] [Google Scholar]
- 46.Karpova A, Mikhaylova M, Thomas U, Knopfel T, Behnisch T. Involvement of protein synthesis and degradation in long-term potentiation of Schaffer collateral CA1 synapses. J Neurosci. 2006;26:4949–4955. doi: 10.1523/JNEUROSCI.4573-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kim JH, Park KC, Chung SS, Bang O, Chung CH. Deubiquitinating enzymes as cellular regulators. J Biochem. 2003;134:9–18. doi: 10.1093/jb/mvg107. [DOI] [PubMed] [Google Scholar]
- 48.Kim JJ, Fanselow MS. Modality-specific retrograde amnesia of fear. Science. 1992;256:675–677. doi: 10.1126/science.1585183. [DOI] [PubMed] [Google Scholar]
- 49.Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70–73. doi: 10.1038/ng0197-70. [DOI] [PubMed] [Google Scholar]
- 50.Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550–563. doi: 10.1038/nrm2731. [DOI] [PubMed] [Google Scholar]
- 51.Kwon YT, Reiss Y, Fried VA, Hershko A, Yoon JK, Gonda DK, Sangan P, Copeland NG, Jenkins NA, Varshavsky A. The mouse and human genes encoding the recognition component of the N-end rule pathway. Proc Natl Acad Sci U S A. 1998;95:7898–7903. doi: 10.1073/pnas.95.14.7898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lee JL. Memory reconsolidation mediates the strengthening of memories by additional learning. Nat Neurosci. 2008;11:1264–1266. doi: 10.1038/nn.2205. [DOI] [PubMed] [Google Scholar]
- 53.Lee SH, Choi JH, Lee N, Lee HR, Kim JI, Yu NK, Choi SL, Lee SH, Kim H, Kaang BK. Synaptic protein degradation underlies destabilization of retrieved fear memory. Science. 2008;319:1253–1256. doi: 10.1126/science.1150541. [DOI] [PubMed] [Google Scholar]
- 54.Li M, Shin YH, Hou L, Huang X, Wei Z, Klann E, Zhang P. The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory. Nat Cell Biol. 2008 doi: 10.1038/ncb1768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Liu J, Liu MC, Wang KK. Calpain in the CNS: from synaptic function to neurotoxicity. Sci Signal. 2008;1:re1. doi: 10.1126/stke.114re1. [DOI] [PubMed] [Google Scholar]
- 56.Lopez-Salon M, Alonso M, Vianna MR, Viola H, Mello e Souza T, Izquierdo I, Pasquini JM, Medina JH. The ubiquitin-proteasome cascade is required for mammalian long-term memory formation. Eur J Neurosci. 2001;14:1820–1826. doi: 10.1046/j.0953-816x.2001.01806.x. [DOI] [PubMed] [Google Scholar]
- 57.Mabb AM, Ehlers MD. Ubiquitination in Postsynaptic Function and Plasticity. Annu Rev Cell Dev Biol. 2010 doi: 10.1146/annurev-cellbio-100109-104129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44:5–21. doi: 10.1016/j.neuron.2004.09.012. [DOI] [PubMed] [Google Scholar]
- 59.Manchado E, Eguren M, Malumbres M. The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functions. Biochem Soc Trans. 2010;38:65–71. doi: 10.1042/BST0380065. [DOI] [PubMed] [Google Scholar]
- 60.Mao LM, Wang W, Chu XP, Zhang GC, Liu XY, Yang YJ, Haines M, Papasian CJ, Fibuch EE, Buch S, Chen JG, Wang JQ. Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine. Nat Neurosci. 2009;12:602–610. doi: 10.1038/nn.2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Martin SJ, Grimwood PD, Morris RG. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci. 2000;23:649–711. doi: 10.1146/annurev.neuro.23.1.649. [DOI] [PubMed] [Google Scholar]
- 62.Meiners S, Ludwig A, Stangl V, Stangl K. Proteasome inhibitors: poisons and remedies. Medicinal research reviews. 2008;28:309–327. doi: 10.1002/med.20111. [DOI] [PubMed] [Google Scholar]
- 63.Morris RG, Inglis J, Ainge JA, Olverman HJ, Tulloch J, Dudai Y, Kelly PA. Memory reconsolidation: sensitivity of spatial memory to inhibition of protein synthesis in dorsal hippocampus during encoding and retrieval. Neuron. 2006;50:479–489. doi: 10.1016/j.neuron.2006.04.012. [DOI] [PubMed] [Google Scholar]
- 64.Muller U, Carew TJ. Serotonin induces temporally and mechanistically distinct phases of persistent PKA activity in Aplysia sensory neurons. Neuron. 1998;21:1423–1434. doi: 10.1016/s0896-6273(00)80660-1. [DOI] [PubMed] [Google Scholar]
- 65.Nader K, Einarsson EO. Memory reconsolidation: an update. Ann N Y Acad Sci. 2010;1191:27–41. doi: 10.1111/j.1749-6632.2010.05443.x. [DOI] [PubMed] [Google Scholar]
- 66.Nader K, Schafe GE, Le Doux JE. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature. 2000;406:722–726. doi: 10.1038/35021052. [DOI] [PubMed] [Google Scholar]
- 67.Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature. 2006;443:768–773. doi: 10.1038/nature05289. [DOI] [PubMed] [Google Scholar]
- 68.Patrick GN, Bingol B, Weld HA, Schuman EM. Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs. Curr Biol. 2003;13:2073–2081. doi: 10.1016/j.cub.2003.10.028. [DOI] [PubMed] [Google Scholar]
- 69.Pettigrew DB, Smolen P, Baxter DA, Byrne JH. Dynamic properties of regulatory motifs associated with induction of three temporal domains of memory in aplysia. J Comput Neurosci. 2005;18:163–181. doi: 10.1007/s10827-005-6557-0. [DOI] [PubMed] [Google Scholar]
- 70.Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 1992;106:274–285. doi: 10.1037//0735-7044.106.2.274. [DOI] [PubMed] [Google Scholar]
- 71.Pines J, Lindon C. Proteolysis: anytime, any place, anywhere? Nat Cell Biol. 2005;7:731–735. doi: 10.1038/ncb0805-731. [DOI] [PubMed] [Google Scholar]
- 72.Reyes-Turcu FE, Wilkinson KD. Polyubiquitin binding and disassembly by deubiquitinating enzymes. Chem Rev. 2009;109:1495–1508. doi: 10.1021/cr800470j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Rial Verde EM, Lee-Osbourne J, Worley PF, Malinow R, Cline HT. Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron. 2006;52:461–474. doi: 10.1016/j.neuron.2006.09.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Rudy JW. Destroying memories to strengthen them. Nat Neurosci. 2008;11:1241–1242. doi: 10.1038/nn1108-1241. [DOI] [PubMed] [Google Scholar]
- 75.Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet. 1999;23:47–51. doi: 10.1038/12647. [DOI] [PubMed] [Google Scholar]
- 76.Sakurai M, Sekiguchi M, Zushida K, Yamada K, Nagamine S, Kabuta T, Wada K. Reduction in memory in passive avoidance learning, exploratory behaviour and synaptic plasticity in mice with a spontaneous deletion in the ubiquitin C-terminal hydrolase L1 gene. Eur J Neurosci. 2008;27:691–701. doi: 10.1111/j.1460-9568.2008.06047.x. [DOI] [PubMed] [Google Scholar]
- 77.Shabek N, Ciechanover A. Degradation of ubiquitin: the fate of the cellular reaper. Cell Cycle. 2010;9:523–530. doi: 10.4161/cc.9.3.11152. [DOI] [PubMed] [Google Scholar]
- 78.Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D, Huganir RL, Worley PF. Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron. 2006;52:475–484. doi: 10.1016/j.neuron.2006.08.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Silva AJ. Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J Neurobiol. 2003;54:224–237. doi: 10.1002/neu.10169. [DOI] [PubMed] [Google Scholar]
- 80.Simpson-Lavy KJ, Oren YS, Feine O, Sajman J, Listovsky T, Brandeis M. Fifteen years of APC/cyclosome: a short and impressive biography. Biochem Soc Trans. 2010;38:78–82. doi: 10.1042/BST0380078. [DOI] [PubMed] [Google Scholar]
- 81.Soh UJ, Dores MR, Chen B, Trejo J. Signal transduction by protease-activated receptors. Br J Pharmacol. 2010;160:191–203. doi: 10.1111/j.1476-5381.2010.00705.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Song H, Smolen P, Av-Ron E, Baxter DA, Byrne JH. Bifurcation and singularity analysis of a molecular network for the induction of long-term memory. Biophys J. 2006;90:2309–2325. doi: 10.1529/biophysj.105.074500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Speese SD, Trotta N, Rodesch CK, Aravamudan B, Broadie K. The ubiquitin proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy. Curr Biol. 2003;13:899–910. doi: 10.1016/s0960-9822(03)00338-5. [DOI] [PubMed] [Google Scholar]
- 84.Stevens CF. A million dollar question: does LTP = memory? Neuron. 1998;20:1–2. doi: 10.1016/s0896-6273(00)80426-2. [DOI] [PubMed] [Google Scholar]
- 85.Stork O, Stork S, Pape HC, Obata K. Identification of genes expressed in the amygdala during the formation of fear memory. Learn Mem. 2001;8:209–219. doi: 10.1101/lm.39401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Tai HC, Schuman EM. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci. 2008;9:826–838. doi: 10.1038/nrn2499. [DOI] [PubMed] [Google Scholar]
- 87.Tronson NC, Taylor JR. Molecular mechanisms of memory reconsolidation. Nat Rev Neurosci. 2007;8:262–275. doi: 10.1038/nrn2090. [DOI] [PubMed] [Google Scholar]
- 88.Upadhya SC, Smith TK, Hegde AN. Ubiquitin-proteasome-mediated CREB repressor degradation during induction of long-term facilitation. J Neurochem. 2004;91:210–219. doi: 10.1111/j.1471-4159.2004.02707.x. [DOI] [PubMed] [Google Scholar]
- 89.van Tijn P, Hol EM, van Leeuwen FW, Fischer DF. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype. Progress in neurobiology. 2008;85:176–193. doi: 10.1016/j.pneurobio.2008.03.001. [DOI] [PubMed] [Google Scholar]
- 90.Wang Y, Luo W, Reiser G. Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell Mol Life Sci. 2008;65:237–252. doi: 10.1007/s00018-007-7288-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Wickliffe K, Williamson A, Jin L, Rape M. The multiple layers of ubiquitin-dependent cell cycle control. Chem Rev. 2009;109:1537–1548. doi: 10.1021/cr800414e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Wood MA, Kaplan MP, Brensinger CM, Guo W, Abel T. Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory. Hippocampus. 2005;15:610–621. doi: 10.1002/hipo.20082. [DOI] [PubMed] [Google Scholar]
- 93.Wright JW, Harding JW. Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction. Neural Plast, 2009. 2009:579382. doi: 10.1155/2009/579382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Wu HY, Lynch DR. Calpain and synaptic function. Mol Neurobiol. 2006;33:215–236. doi: 10.1385/MN:33:3:215. [DOI] [PubMed] [Google Scholar]
- 95.Wu Y, Bolduc FV, Bell K, Tully T, Fang Y, Sehgal A, Fischer JA. A Drosophila model for Angelman syndrome. Proc Natl Acad Sci U S A. 2008;105:12399–12404. doi: 10.1073/pnas.0805291105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Yang Y, Kim AH, Bonni A. The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20-APC regulate neuronal morphogenesis and connectivity. Curr Opin Neurobiol. 2010;20:92–99. doi: 10.1016/j.conb.2009.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Yashiro K, Riday TT, Condon KH, Roberts AC, Bernardo DR, Prakash R, Weinberg RJ, Ehlers MD, Philpot BD. Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci. 2009;12:777–783. doi: 10.1038/nn.2327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Yeh SH, Mao SC, Lin HC, Gean PW. Synaptic expression of glutamate receptor after encoding of fear memory in the rat amygdala. Mol Pharmacol. 2006;69:299–308. doi: 10.1124/mol.105.017194. [DOI] [PubMed] [Google Scholar]
- 99.Yi JJ, Ehlers MD. Ubiquitin and protein turnover in synapse function. Neuron. 2005;47:629–632. doi: 10.1016/j.neuron.2005.07.008. [DOI] [PubMed] [Google Scholar]
- 100.Yi JJ, Ehlers MD. Emerging roles for ubiquitin and protein degradation in neuronal function. Pharmacol Rev. 2007;59:14–39. doi: 10.1124/pr.59.1.4. [DOI] [PubMed] [Google Scholar]
- 101.Zhao Y, Hegde AN, Martin KC. The ubiquitin proteasome system functions as an inhibitory constraint on synaptic strengthening. Curr Biol. 2003;13:887–898. doi: 10.1016/s0960-9822(03)00332-4. [DOI] [PubMed] [Google Scholar]



